Northwest Biotherapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.17 |
Market Cap |
$137.75 M |
Shares Outstanding |
544.47 M |
Public Float |
504.11 M |
Address |
4800 Montgomery Lane Bethesda Maryland 20814 United States |
Employees | - |
Website | http://www.nwbio.com |
Updated | 07/08/2019 |
Northwest Biotherapeutics, Inc. is a clinical stage biotechnology company. The firm engages in the development of cancer vaccines designed to treat solid tumor cancers. It also offers a platform technology for DCVax dendritic cell-based vaccines. |